Expert opinion on the applicability of dyslipidemia guidelines in Asia and the Middle East

por Alshamiri, Mostafa, Ghanaim, Mahmood Mohammed Ali, Barter, Philip, Chang, Kuan-Cheng, Li, Jian-Jun, Matawaran, Bien J, Santoso, Anwar, Shaheen, Sameh, Suastika, Ketut, Thongtang, Nuntakorn, Yusof, Ahmad KM
Publicado 2018

Use of sodium‐glucose co‐transporter‐2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendation...

por Deerochanawong, Chaicharn, Chan, Siew P., Matawaran, Bien J., Sheu, Wayne H.‐H., Chan, Juliana, Man, Nguyen H., Suastika, Ketut, Khoo, Chin M., Yoon, Kun‐Ho, Luk, Andrea, Mithal, Ambrish, Linong, Ji
Publicado 2019

Use of SGLT-2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Abdominal Obesity: An Asian Perspective and Expert Recommendations

por Sheu, Wayne Huey-Herng, Chan, Siew Pheng, Matawaran, Bien J., Deerochanawong, Chaicharn, Mithal, Ambrish, Chan, Juliana, Suastika, Ketut, Khoo, Chin Meng, Nguyen, Huu Man, Linong, Ji, Luk, Andrea, Yoon, Kun-Ho
Publicado 2020

Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes

por Tan, Jack Wei Chieh, Sim, David, Ako, Junya, Almahmeed, Wael, Cooper, Mark E, Dalal, Jamshed J, Deerochanawong, Chaicharn, Huang, David Wei Chun, Johar, Sofian, Kaul, Upendra, Kim, Sin Gon, Koh, Natalie, Kong, Alice Pik-Shan, Krittayaphong, Rungroj, Kwok, Bernard, Matawaran, Bien J, Nguyen, Quang Ngoc, Ong, Loke Meng, Park, Jin Joo, Peng, Yongde, Quek, David KL, Suastika, Ketut, Sukor, Norlela, Teo, Boon Wee, Teoh, Chee Kiang, Zhang, Jian, Reyes, Eugenio B, Goh, Su Yen
Publicado 2021